Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 176 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1751 N/R Advanced breast cancer 4 Chemotherapy
Gene Therapy
Georgetown University Medical Center United States 8/2004
Treatment Details: Patients: This Phase I study involved 22 patients with advanced breast cancer (10 patients) and other tumors (12 patients). Treatment: The treatment consisted of Bcl-2 antisense (G3139 or
 
1752 N/R Metastatic hormone-refractory prostate cancer 5 Chemotherapy
Grampian University Hospitals NHS Trust United Kingdom 8/2002
Treatment Details: Patients: This Phase II study involved 14 patients with hormone refractory metastatic prostate cancer. Median age was 66 years and the median PSA (prior to hormone therapy) was 258. Metast
 
1753 N/R Advanced renal cell carcinoma 4 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 8/2003
Treatment Details: Patients: This Phase II trial involved 18 patients with advanced renal cell carcinoma; 13 men and 5 women. Median age was 59 years. Prior therapies included: nephrectomy (15 patients), rad
 
1754 N/R Advanced renal cell carcinoma 3 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 1/2002
Treatment Details: Patients: This Phase II study involved 26 patients with advanced renal cell carcinoma; 23 men and 3 women. The median age was 58. Prior treatments included nephrectomy (15 patients), immun
 
1755 N/R Advanced renal cell carcinoma 4 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 1/2001
Treatment Details: Patients: This Phase II trial involved 13 patients with advanced renal cell carcinoma; 9 men and 4 women. Median age was 55 years. Prior therapies included nephrectomy (8 patients), immuno
 
1756 N/R Metastatic renal cell carcinoma 3 Chemotherapy
University of Chicago United States 8/2002
Treatment Details: Patients: This Phase II trial involved 12 patients with metastatic renal cell carcinoma; seven men and 5 women. The median age was 59. Eight of the patients had undergone a prior nephrecto
 
1757 N/R Locally advanced or metastatic renal cell carcinoma 2 Chemotherapy
University of Minnesota Medical School United States 2/2002
Treatment Details: Patients: This Phase II study involved 12 patients with locally advanced or metastatic renal cell carcinoma; 8 men and 4 women. The median age was 56. All patients had received prior immun
 
1758 N/R Advanced breast cancer 3 Biologic therapy
University of Erlangen-Nurnberg Germany 12/2003
Treatment Details: Patients: This Phase I trial involved 30 women with advanced breast cancer. Treatment: The treatment consisted of the bispecific antibody MDX-H210 (anti-FcyR1 and anti-HER-2/neu).
 
1759 N/R colorectal 4 Biologic therapy
Tom Connors Cancer Research Center United Kingdom 8/2005
Treatment Details: Patients: This Phase I study involved 32 patients with advanced solid-tissue tumors, and 31 were evaluated. Twenty-three of these patients were men, and nine were women. The median age was
 
1760 N/R colon cancer 3 Biologic therapy
Massachusetts General Hospital United States 8/2005
Treatment Details: Patients: This Phase I study involved 19 patients with advanced solid-tissue tumors. Eleven of these patients were men, and eight were women. The average age was 53.7 years. All patients
 
Page 176 of 187  | Previous Page  | Next Page